WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/19/2021
Back to search
Official data from USPTO
FIVEPRIME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
08/19/2021
Trademark type
Combined
Nice classes
5, 42
Filing date
01/09/2003
Registration date
02/12/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2018
Last transaction
08/01/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/17/2007
First use in commerce
04/17/2007
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
SINGH, TEJBIR
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Representatives
Five Prime Therapeutics, Inc.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the diagnosis of human diseases or human health-related conditionswith diagnosis being limited to the identification of human patient populations for administering preventatives or therapeutics and monitoring the human patient populations' response thereto; pharmaceutical preparations for the prevention or treatment of human diseases or human health-related conditions
Class 42
Research of pharmaceutical products for the diagnosis of human disease or human health-related conditionswith diagnosis being limited to the identification of human patient populations for administering preventatives or therapeutics and monitoring the human patient populations' response thereto; research of pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; development and design of pharmaceutical products for the diagnosispreventiontreatment of human diseases or human health-related conditions; testing of pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; pharmaceutical product and technology consultation and screening services
Publications
History of USPTO decisions and trademark events.
61 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/19/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/01/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/01/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/01/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/01/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
07/19/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/19/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/24/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/24/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/12/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/12/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/12/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2014
E815
TEAS SECTION 8 & 15 RECEIVED
07/29/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/11/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/11/2012
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/03/2008
PLGL
ASSIGNED TO PARALEGAL
04/07/2008
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/21/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
01/05/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/04/2008
ALIE
ASSIGNED TO LIE
01/04/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/11/2007
IUAF
USE AMENDMENT FILED
11/19/2007
PAPER RECEIVED
11/19/2007
CORV
REVIEW OF CORRESPONDENCE COMPLETE
08/15/2007
FAXX
FAX RECEIVED
08/13/2007
EX5G
SOU EXTENSION 5 GRANTED
08/13/2007
EXT5
SOU EXTENSION 5 FILED
05/11/2007
EEXT
SOU TEAS EXTENSION RECEIVED
05/11/2007
EX4G
SOU EXTENSION 4 GRANTED
01/12/2007
EXT4
SOU EXTENSION 4 FILED
11/08/2006
PAPER RECEIVED
11/08/2006
EX3G
SOU EXTENSION 3 GRANTED
06/13/2006
EXT3
SOU EXTENSION 3 FILED
05/23/2006
PAPER RECEIVED
05/23/2006
EX2G
SOU EXTENSION 2 GRANTED
11/18/2005
EXT2
SOU EXTENSION 2 FILED
11/02/2005
PAPER RECEIVED
11/02/2005
DOCK
ASSIGNED TO EXAMINER
08/11/2005
EX1G
SOU EXTENSION 1 GRANTED
06/08/2005
EXT1
SOU EXTENSION 1 FILED
05/20/2005
PAPER RECEIVED
05/20/2005
DOCK
ASSIGNED TO EXAMINER
01/07/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/23/2004
PUBO
PUBLISHED FOR OPPOSITION
08/31/2004
NPUB
NOTICE OF PUBLICATION
08/11/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2004
CNEA
EXAMINERS AMENDMENT MAILED
05/27/2004
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/25/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2004
PAPER RECEIVED
03/29/2004
CNFR
FINAL REFUSAL MAILED
02/05/2004
CFIT
CASE FILE IN TICRS
12/08/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2003
PAPER RECEIVED
11/06/2003
CNRT
NON-FINAL ACTION MAILED
06/25/2003
DOCK
ASSIGNED TO EXAMINER
06/23/2003
Continuous trademark protection
Get notified about every new filing that threatens FIVEPRIME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.